Financhill
Back

CRISPR Therapeutics AG Quote, Financials, Valuation and Earnings

CRISPR Therapeutics AG Price Quote

$40.74
+0.02 (+0.88%)
(Updated: December 21, 2024 at 5:21 AM ET)

CRISPR Therapeutics AG Key Stats

Sell
28
CRISPR Therapeutics AG (CRSP) is a Sell

Day range:
$39.41 - $41.02
52-week range:
$39.41 - $91.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.79%

Volume:
3.1M
Avg. volume:
2M
1-year change:
-33.04%
Market cap:
$3.5B
Revenue:
$370M
EPS:
$-2.8

How Much Does CRISPR Therapeutics AG Make?

Data Unavailable

Is CRISPR Therapeutics AG Growing As A Company?

Data Unavailable

CRISPR Therapeutics AG Stock Price Performance

What Is CRISPR Therapeutics AG 52-Week High & Low?

CRISPR Therapeutics AG Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CRISPR Therapeutics AG?

Data Unavailable

Is CRISPR Therapeutics AG Cash Flow Positive?

Data Unavailable

CRISPR Therapeutics AG Return On Invested Capital

Data Unavailable

CRISPR Therapeutics AG Earnings Date & Stock Price

CRISPR Therapeutics AG Competitors

CRISPR Therapeutics AG Dividend Yield

Data Unavailable

CRISPR Therapeutics AG Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 28.11%
Revenue: 0% -91.56%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 11
Sell Recommendations: 2
Price Target: 81.75
Upside from Last Price: 100.76%

Major Shareholders

Data Unavailable